Hylton NM - Search Results

1

Repeatability and Reproducibility of ADC Histogram Metrics from the ACRIN 6698 Breast Cancer Therapy Response Trial.

Newitt DC, Amouzandeh G, Partridge SC, Marques HS, Herman BA, Ross BD, Hylton NM, Chenevert TL, Malyarenko DI. Newitt DC, et al. Among authors: hylton nm. Tomography. 2020 Jun;6(2):177-185. doi: 10.18383/j.tom.2020.00008. Tomography. 2020. PMID: 32548294 Free PMC article.

2

Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging.

Hylton NM. Hylton NM. Magn Reson Imaging Clin N Am. 1999 May;7(2):411-20, x. Magn Reson Imaging Clin N Am. 1999. PMID: 10382170 Review.

3

Semi-automated analysis for MRI of breast tumors.

Partridge SC, Heumann EJ, Hylton NM. Partridge SC, et al. Among authors: hylton nm. Stud Health Technol Inform. 1999;62:259-60. Stud Health Technol Inform. 1999. PMID: 10538368

4

MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer.

Esserman L, Kaplan E, Partridge S, Tripathy D, Rugo H, Park J, Hwang S, Kuerer H, Sudilovsky D, Lu Y, Hylton N. Esserman L, et al. Ann Surg Oncol. 2001 Jul;8(6):549-59. doi: 10.1007/s10434-001-0549-8. Ann Surg Oncol. 2001. PMID: 11456056

5

Menstrual cycle variation of apparent diffusion coefficients measured in the normal breast using MRI.

Partridge SC, McKinnon GC, Henry RG, Hylton NM. Partridge SC, et al. Among authors: hylton nm. J Magn Reson Imaging. 2001 Oct;14(4):433-8. doi: 10.1002/jmri.1204. J Magn Reson Imaging. 2001. PMID: 11599068

6

Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy.

Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Sudilovsky D, Hylton NM. Partridge SC, et al. Among authors: hylton nm. AJR Am J Roentgenol. 2002 Nov;179(5):1193-9. doi: 10.2214/ajr.179.5.1791193. AJR Am J Roentgenol. 2002. PMID: 12388497

7

MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival.

Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Tripathy D, Wolverton DS, Rugo HS, Hwang ES, Ewing CA, Hylton NM. Partridge SC, et al. Among authors: hylton nm. AJR Am J Roentgenol. 2005 Jun;184(6):1774-81. doi: 10.2214/ajr.184.6.01841774. AJR Am J Roentgenol. 2005. PMID: 15908529

8

Characterization of breast lesions using the 3D FIESTA sequence and contrast-enhanced magnetic resonance imaging.

Klifa CS, Shimakawa A, Siraj Z, Gibbs JE, Wilmes LJ, Partridge SC, Proctor E, Hylton NM. Klifa CS, et al. Among authors: hylton nm. J Magn Reson Imaging. 2007 Jan;25(1):82-8. doi: 10.1002/jmri.20775. J Magn Reson Imaging. 2007. PMID: 17173311

9

AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.

Wilmes LJ, Pallavicini MG, Fleming LM, Gibbs J, Wang D, Li KL, Partridge SC, Henry RG, Shalinsky DR, Hu-Lowe D, Park JW, McShane TM, Lu Y, Brasch RC, Hylton NM. Wilmes LJ, et al. Among authors: hylton nm. Magn Reson Imaging. 2007 Apr;25(3):319-27. doi: 10.1016/j.mri.2006.09.041. Epub 2007 Feb 5. Magn Reson Imaging. 2007. PMID: 17371720

10

Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging.

Li KL, Partridge SC, Joe BN, Gibbs JE, Lu Y, Esserman LJ, Hylton NM. Li KL, et al. Among authors: hylton nm. Radiology. 2008 Jul;248(1):79-87. doi: 10.1148/radiol.2481070846. Radiology. 2008. PMID: 18566170 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

191 results

Search Page